DRIO (DarioHealth) LT-Debt-to-Total-Asset: 0.30 (As of Mar. 2026)

What is DarioHealth LT-Debt-to-Total-Asset?

DarioHealth DRIO +7.85% 58 LT-Debt-to-Total-Asset is 0.30 as of Mar. 2026. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.10 (Fairly Valued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. DarioHealth's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.30.

DarioHealth's long-term debt to total assets ratio increased from Mar. 2025 (0.17) to Mar. 2026 (0.30). It may suggest that DarioHealth is progressively becoming more dependent on debt to grow their business.

DarioHealth (NAS:DRIO) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

DarioHealth LT-Debt-to-Total-Asset Related Terms

DarioHealth LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for DarioHealth's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth LT-Debt-to-Total-Asset Chart

DarioHealth Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.00

0.16

0.26

0.20

0.29

DarioHealth Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.17	0.29	0.27	0.29	0.30

58GF Score

DarioHealth Corp DRIO

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

DarioHealth LT-Debt-to-Total-Asset Calculation

DarioHealth's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	31.318	/	110.075
	=	0.28

DarioHealth's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	31.438	/	103.281
	=	0.30

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.30 mean?

DarioHealth (DRIO) has a LT-Debt-to-Total-Asset of 0.30 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on DarioHealth and its competitors.

Is DarioHealth's LT-Debt-to-Total-Asset too high?

DarioHealth's current LT-Debt-to-Total-Asset is 0.30. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does DarioHealth's LT-Debt-to-Total-Asset compare to BEAT and ONMD?

DarioHealth's LT-Debt-to-Total-Asset of 0.30 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Healthcare Providers & Services company?

A good LT-Debt-to-Total-Asset depends on the Healthcare Providers & Services industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on DarioHealth and its competitors. DarioHealth's current LT-Debt-to-Total-Asset is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is DarioHealth stock overvalued right now?

Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.10, compared to a current price of $7.26 — trading 2.2% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.30. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For DarioHealth (DRIO), the current LT-Debt-to-Total-Asset is 0.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.26 is trading 2.2% above its estimated GF Value™ of $7.10. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

LT-Debt-to-Total-Asset: 0.30
GF Value™: $7.10 vs. price of $7.26 (2.2% above fair value)
GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies BEAT ONMD CRVW VASO DH PBSV BFRG CCLD BRGX VYND VEEV ASX:PME BTSG TEM HQY TSE:2413 HNGE TXG DOCS WAY

Address 322 West 57th Street, New York, NY, USA, 10019

Website https://www.mydario.com

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

58GF Score

Get the complete analysis for DRIO

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.26

Price

$7.10

GF Value

View DRIO Analysis

See LT-Debt-to-Total-Asset data for all stocks →